Recent Updates
Recently added Catalysts
PEN Positive Sentiment

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025 Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 ...

Key Takeaway: Penumbra, Inc. has scheduled a conference call for February 18, 2025, after market close, to discuss its financial results for the fourth quarter and full year 2024. A press release with the financial results will be available prior to the call. The webcast will be accessible for at least two weeks following the call on the company's website. Penumbra is recognized as a leader in thrombectomy technologies, improving patient care through innovative solutions.
Price reaction · baseline $263.69 (2025-01-17 close) · hit after-hours · clean, no other PEN news in the window
day 0 close
+1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Penumbra is hosting a conference call to discuss strong financial results.
  • The company is positioned as a leader in thrombectomy technology.
  • They are improving patient outcomes globally with their innovative solutions.

Full Press Release Details

ALAMEDA, Calif. , Jan. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 after market close on Tuesday, February 18, 2025 at 4:30 PM Eastern Time . A press release with fourth quarter and full year 2024 financial results will be issued after market close that day.
Webcast & Conference Call Information The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 5872954), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com . The webcast will be available on the company's website for at least two weeks following the completion of the call.
About Penumbra Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram , LinkedIn and X .
Investor Relations Penumbra, Inc. [email protected]

Frequently Asked Questions

When will Penumbra announce its 2024 financial results?

Penumbra will announce its 2024 financial results on February 18, 2025.

How can I access Penumbra's conference call?

You can call (888) 596-4144 or access the webcast on Penumbra's website.

What is Penumbra's primary focus?

Penumbra focuses on developing innovative thrombectomy technologies.

How long will the webcast be available after the call?

The webcast will be available on the website for at least two weeks.

In how many countries does Penumbra operate?

Penumbra operates in over 100 countries worldwide.

Last updated: Jan 21, 2025